Abstract 264P
Background
Cancer-related cognitive impairment (CRCI), affecting up to 80% of breast cancer (BC) patients, manifests in various cognitive domains such as learning, memory, and concentration. The hippocampus, crucial for these cognitive processes and known to retain its neurogenesis capacity throughout adulthood, is susceptible to morphological alterations due to BC treatment. Recent research highlights the link between physical exercise and neurogenesis. This study aims to investigate CRCI and the potential effects of high-intensity interval training (HIIT) on learning, memory, and concentration function, as well as brain morphology in BC patients undergoing treatment.
Methods
This randomized (1:1) controlled trial allocated early-stage BC patients to either a HIIT intervention group (IG) or a control group (CG). The intervention involved a 12-month supervised HIIT program tailored through cardio-pulmonary exercise testing. Learning, memory, and concentration function were assessed using the California Verbal Learning Test (CVLT) alongside the Wechsler Memory Scale (WMS). Hippocampal volume was evaluated with MRI-based free surfer analysis. Assessments were conducted at baseline and after 12 months.
Results
A total of 69 patients (mean age 50.67 years, SD 10.55; 98.5% female) were recruited. The analysis showed no statistically significant changes in total hippocampal volume in either group (IG: p = 0.25 and p = 0.39; CG: p = 0.25 and p = 0.33). Similarly, no significant changes were observed in the CVLT scores for both groups (IG: p = 0.102; CG: p = 0.059). However, compared to the CG, the IG exhibited significant improvements in the WMS (p < 0.05).
Conclusions
Assessing CRCI in BC patients is challenging. Despite a multimodal approach, we couldn't objectify structural or functional adverse effects on specific cognitive subdomains. Although HIIT exercise during chemotherapy didn't notably impact learning and memory, it did enhance concentration over time. This might suggest that cognitive function in BC patients benefits from exercising.
Clinical trial identification
NCT04789187. Registered on 09 March 2021.
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Verein zur Forschungsförderung der Krebshilfe OÖ.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
302P - Perceptions of women with HER2+ breast cancer on the risk of recurrence and disease management: Results from the ASKHER survey
Presenter: Matteo Lambertini
Session: Poster session 14
303P - Predicting quality of life trajectories in young women with breast cancer: 5-year results from a large prospective cohort
Presenter: Bryan Vaca-Cartagena
Session: Poster session 14
304P - Impact of estrogen receptor positivity for adjuvant endocrine therapy in luminal T1a/bN0M0 breast cancer: A multi-institutional retrospective observational study
Presenter: Shinsuke Sasada
Session: Poster session 14
305P - Prognosis of isolated locoregional recurrence after early breast cancer with immediate breast reconstruction surgery: A retrospective multi-institutional study
Presenter: Hirohito Seki
Session: Poster session 14
306P - Patient-reported symptoms in early breast cancer and future cardiovascular events: A province-wide administrative database study
Presenter: Edith Pituskin
Session: Poster session 14
307P - Exposure to Di-2-ethylhexyl phthalate and breast cancer incidence: A cohort study
Presenter: Lijuan Tang
Session: Poster session 14
308P - Impact of the COVID-19 (C19) pandemic on breast cancer (BC) treatment patterns in the US
Presenter: Mariana Chavez Mac Gregor
Session: Poster session 14
310P - Identification of racial disparities across MammaPrint and BluePrint subtypes in HR+HER2- breast cancer
Presenter: Sonya Reid
Session: Poster session 14
311P - Optimizing breast cancer staging: Redefining tumor size classification using big data analytics
Presenter: Bin Feng
Session: Poster session 14